Article Details

Analysts Anticipate Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Will Post Quarterly Sales of ...

Retrieved on: 2021-03-03 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

Analysts Anticipate Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Will Post Quarterly Sales of .... View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 46,331 shares of the company's stock valued at $410,000 after purchasing an additional 7,203 shares during ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up